A On Wednesday, the Federal judge prevented the Trump administration from cutting the financing of medical research significantly, which many scientists say will endanger patients and cost them jobs.
The new national institutes for health policy will strip the research groups of hundreds of millions of dollars to cover the so-called indirect expenses to study Alzheimer’s, cancer, heart disease and a group of other diseases-any of the clinical trials of new treatments to basic laboratory research that are the basis for discoveries.
A separate lawsuit submitted by a group of 22 states in addition to organizations representing universities, hospitals and research institutions worldwide to stop the discounts, saying that it will cause “irreplaceable damage.”
The American boycott judge Angel Kelly in Boston temporarily prevented the cuts last month. On Wednesday, I made a preliminary judicial order that puts the cuts longer, while the claims continue.
Read more: What should you know about Jae Bhatershara, Trump’s choice of leading the National Institutes of Health
The National Institutes of Health granted the main texture of biomedical research, about $ 35 billion of grants to research groups last year. The total is divided into “direct” costs – which cover the salaries of researchers and laboratory supplies – and “indirect” costs, and the administrative costs and facilities necessary to support this work.
The Trump administration has rejected these expenses as “general”, but universities and hospitals argue that they are more important. It can include things such as electricity to operate advanced machines and get rid of dangerous waste and employees who guarantee researchers to follow safety rules and pairing workers.
Under the previous policy, the government negotiated these prices with institutions. For example, the institution with an indirect cost rate of 50 % will get $ 50,000 to cover the indirect expenses of a project worth $ 100,000. The policy of the National Institutes of New Health will lead to indirect cost costs at a fixed rate of 15 % instead, calculated to provide the agency $ 4 billion a year.